All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2016-004580-39 | Treatment of Growth Hormone Deficiency associated with Chronic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Study TRATTAMENTO DEL DEFICIT DI GH ASSOCIATO AD INSUFFICIENZA CARDIACA ... | not-yet-due | |
Exempt | 2017-000687-16 | Novel avenues for the rescue of intellectual disability in Down syndrome NUOVE STRATEGIE PER IL RECUPERO DELLA DISABILIT¿ INTELLETTIVA NELLA SINDROME DI DOWN | not-yet-due | |
Completed, but no date | 2017-001261-25 | PHARMACOLOGICAL, NO PROFIT, PROSPECTIVE RANDOMIZED, DOUBLE-BLIND PLACEBO, CONTROLLED STUDY TO EVALUATE THE EFFICACY OF LEVOTHYROXINE AND LIOTIRONINE (LT4+LT3) IN POST-SURGICAL HYPOTHYROIDISM PATIENTS... | bad-data | |
Ongoing | 2019-002202-43 | Effects of empagliflozin on cardiac remodeling and myocardial sympathetic nervous system in diabetic patients affected by chronic heart failure Effetti di empagliflozin sul rimodellamento cardiaco ... | not-yet-due | |
Ongoing | 2019-002391-13 | Platelet inhibition with Ticagrelor 60 mg versus Ticagrelor 90 mg twice daily in elderly patients with acute coronary syndrome (ACS). Inibizione dell'aggregazione piastrinica con Ticagrelor 60 mg v... | not-yet-due |